DARK FOREST CAPITAL MANAGEMENT LP
Position in BIO — Bio-Rad Laboratories, Inc.
CIK 1853322
NEW YORK, NY
Position in BIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$651,520
-$280,620 QoQ
Shares Held
2,219
-33.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#195
of 396 holders
Holding Since
Sep 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026DARK FOREST CAPITAL MANAGEMENT LP holds $15,536,015 across 13 Medical Devices names. BIO ranks #7 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
98,856 | $4,219,174 | |
| 2 | STE |
STERIS plc
|
10,534 | $2,218,144 | |
| 3 | IRMD |
Iradimed Corp
|
21,579 | $2,062,089 | |
| 4 | DXCM |
Dexcom Inc
|
28,068 | $1,890,379 | |
| 5 | NVCR |
NovoCure Ltd
|
79,908 | $1,210,606 | |
| 6 | BFLY |
Butterfly Network, Inc.
|
84,477 | $711,296 | |
| 7 | BIO |
Bio-Rad Laboratories, Inc.
This page
|
2,219 | $651,520 | |
| 8 | ENOV |
Enovis CORP
|
28,759 | $595,311 |
All Filings in BIO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $651,520 | 2,219 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $932,140 | 3,344 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $647,140 | 2,308 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,108,865 | 4,595 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $219,149 | 655 | Shares | Sole | 2024-11-14 | |
| 2023-03-31 | $60,356 | 126 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,204 | 10 | Shares | Sole | 2023-02-13 | |
| 2022-03-31 | $18,586 | 33 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,822 | 13 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,983 | 4 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||